209 filings
Page 4 of 11
8-K
syrlqz219b6hm5
16 Dec 22
Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:05am
424B5
mduwoh6
16 Dec 22
Prospectus supplement for primary offering
7:00am
S-8
bjycps5d8mhe8u
9 Dec 22
Registration of securities for employees
5:01pm
8-K
x97vmty
5 Dec 22
Checkpoint Therapeutics Announces Reverse Stock Split
4:45pm
DEF 14C
3b3kwgso465cvq6y
14 Nov 22
Information statement
5:00pm
8-K
1fz0vsj89 6dcs71w
8 Nov 22
Checkpoint Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
5:43pm
PRE 14C
gci knhr27lryxy9
4 Nov 22
Preliminary information
5:22pm
8-K
gqq 98mijg5f
4 Nov 22
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
bswb5j013iv7n51v
12 Aug 22
Checkpoint Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
8:15am
8-K
8w8ytj y5rx5ng1m1fwc
21 Jul 22
Changes in Registrant's Certifying Accountant
5:00pm
8-K
9jygf0ir
16 Jun 22
Other Events
7:45am
8-K
wluueso332kcej rv51
15 Jun 22
Submission of Matters to a Vote of Security Holders
5:26pm
8-K
ny48zt0m09q2uup3lzu6
12 May 22
Checkpoint Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights
4:45pm
CT ORDER
sl7elide
12 May 22
Confidential treatment order
7:42am
DEFA14A
3jy0duioqdg7pp ltu
29 Apr 22
Additional proxy soliciting materials
8:47am